Abstract |
The mechanism underlying the intraocular pressure (IOP) lowering effect of a prostaglandin-related compound, isopropyl 20-ethyl-9 alpha,11 alpha-dihydroxy-15-keto-cis-delta 5-prostanoate (UF-021), and its possible adverse effects in long-term use were studied in normal human eyes. A single instillation of 0.12% UF-021 significantly lowered IOP without affecting aqueous flow rate, tonographic C value or episcleral venous pressure. Protein concentration in the anterior chamber and corneal endothelial permeability to fluorescein remained unaffected. It was suggested that UF-021 lowers IOP mainly by increasing uveoscleral outflow. Twice daily application of 0.12% UF-021 for 4 weeks caused no significant changes in aqueous protein concentration, aqueous flow rate or corneal endothelial permeability. Neither single nor long-term use of topical UF-021 induced irritative responses in the outer segment of the eye. The present study suggests that UF-021 has potential as a safe and effective ocular hypotensive drug with a mechanism of action different from other drugs currently available for the treatment of glaucoma.
|
Authors | M Sakurai, M Araie, T Oshika, M Mori, K Masuda, R Ueno, M Takase |
Journal | Japanese journal of ophthalmology
(Jpn J Ophthalmol)
Vol. 35
Issue 2
Pg. 156-65
( 1991)
ISSN: 0021-5155 [Print] Japan |
PMID | 1779485
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Eye Proteins
- isopropyl unoprostone
- Dinoprost
|
Topics |
- Administration, Topical
- Adult
- Anterior Chamber
(metabolism)
- Aqueous Humor
(chemistry, drug effects, metabolism)
- Dinoprost
(analogs & derivatives, pharmacology)
- Endothelium, Corneal
(metabolism)
- Eye Proteins
(analysis)
- Fluorophotometry
- Humans
- Intraocular Pressure
(drug effects)
- Permeability
- Pupil
(drug effects)
- Random Allocation
- Sclera
(blood supply)
- Tonometry, Ocular
|